digiMedical Solutions, Inc.(TM) Focuses on New Sales Channels With Launch of digiRX Digital Prescription Web Portal

  digiMedical Solutions, Inc.(TM)
(PINKSHEETS: DGMS) today launched a website that will be the focal point of
the services offered by digiMedical's product digiRX(TM).  The new website
can be reviewed at www.digirx.com.

digiRX(TM) is an acute care digital medical software system that provides services to physicians, patients and pharmacies. The digiRX(TM) software addresses the movement of prescriptions from the physician's office to the pharmacy, with a focus on controlling the movement of Schedule II drugs, such as OxiContin. digiRX(TM) is a thin-client system thus allowing updates to be instantaneous to the end users. "Thin-client" means that users only need an Internet browser to access the product. digiRX(TM) has ancillary services providing detailed history to nurses, physicians and pharmacists and the means to transmit prescriptions securely to any pharmacy.

To learn more about digiRX(TM) or any of the Company's digital medical software products, please contact the company at [e-mail] or [phone] x 111. To be added to digiMedical's corporate e-mail list to receive company updates, please send an e-mail to [e-mail].

About digiMedical Solutions, Inc.(TM) (www.digiMedical.com)

digiMedical Solutions, Inc.(TM) is a pharmacy and medical technology company focused on developing next generation, digital medical technology with an emphasis on digital prescriptions (d-Prescriptions) that closely align the doctor, pharmacist and patient. The company's planned growth will come from three channels: direct marketing of the company's wireless based d-prescription technology to physicians, direct marketing of the company's digital call center services for refills and reauthorization and partnering with independent pharmacy chains to focus sales with the technology suite.

Forward-Looking Statement

Statements included in this press release which are not historical in nature, are intended to be, and are hereby identified as "Forward-Looking Statements" for purposes of safe harbor provided by Section 21E of the Securities Exchange Act of 1934, as amended. Forward-Looking Statements may be identified by words including "anticipate," "await," "envision," "foresee," "aim at," "believe," "intends," "estimates" including without limitation, those relating to the company's future business prospects, are subject to certain risks and uncertainties that could cause actual results to differ materially from those indicated in the Forward-Looking Statements. Readers are directed to the company's filings with the U.S. Securities and Exchange Commission.

Add to Digg Bookmark with del.icio.us Add to Newsvine

Contact: digiMedical Solutions, Inc. Investor Relations 214-722-3029 [e-mail] www.digimedical.com